Mark Willingham Selected Research

Mark Willingham Research Topics

Disease

9	Neoplasms (Cancer) 06/2016 - 08/2002
2	Colonic Neoplasms (Colon Cancer) 01/2020 - 08/2002
2	Thyroid Neoplasms (Thyroid Cancer) 06/2016 - 10/2012
2	Vesicular Stomatitis 04/2014 - 03/2013
2	Prostatic Neoplasms (Prostate Cancer) 07/2009 - 03/2002
2	Inflammation (Inflammations) 01/2007 - 09/2003
2	Ovarian Neoplasms (Ovarian Cancer) 01/2006 - 08/2005
1	Acute Kidney Injury (Acute Renal Failure) 03/2020
1	Postoperative Pain 02/2020
1	Pain (Aches) 02/2020
1	Anaplasia 06/2016
1	Obesity 06/2016
1	Melanoma (Melanoma, Malignant) 03/2013
1	Infections 03/2013
1	Virus Diseases (Viral Diseases) 03/2013
1	follicular Thyroid cancer 10/2012
1	Carcinogenesis 01/2012
1	Mesothelioma 01/2006
1	Neoplasm Metastasis (Metastasis) 08/2005
1	Breast Neoplasms (Breast Cancer) 02/2004
1	Xanthomatosis (Xanthoma) 09/2003
1	Atherosclerosis 09/2003
1	Testicular Neoplasms (Testicular Cancer) 03/2002

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 03/2013 - 03/2002
2	IntegrinsIBA 06/2016 - 10/2012
2	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 10/2012 - 01/2012
2	CholesterolIBA 01/2007 - 09/2003
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2007 - 09/2003
2	MesothelinIBA 01/2006 - 08/2005
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2006 - 08/2005
1	Opioid Analgesics (Opioids)IBA 02/2020
1	P-30 composite resin (P 30)IBA 01/2020
1	Fibronectins (Fibronectin)IBA 06/2016
1	Metformin (Glucophage)FDA LinkGeneric 06/2016
1	Mutant Proteins (Protein, Mutant)IBA 04/2014
1	3- (4,5- dimethylthiazol- 2- yl)- 5- (3- carboxymethoxyphenyl)- 2- (4- sulfophenyl)- 2H- tetrazoliumIBA 03/2013
1	Vesicular stomatitis virus M proteinIBA 03/2013
1	Antiviral Agents (Antivirals)IBA 03/2013
1	Focal Adhesion Protein-Tyrosine KinasesIBA 10/2012
1	CyclinsIBA 10/2012
1	Metalloproteases (Metalloproteinases)IBA 10/2012
1	Thyroid HormonesIBA 10/2012
1	RacivirIBA 10/2012
1	Retinoblastoma ProteinIBA 01/2012
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2012
1	Oncogene Proteins (Oncogene Protein)IBA 01/2012
1	Apoptosis Regulatory ProteinsIBA 07/2009
1	Small Interfering RNA (siRNA)IBA 07/2009
1	Phosphotransferases (Kinase)IBA 07/2009
1	Tumor Biomarkers (Tumor Markers)IBA 01/2006
1	Trastuzumab (Herceptin)FDA Link 02/2004
1	Dietary Fats (Dietary Fat)IBA 09/2003
1	LDL Receptors (LDL Receptor)IBA 09/2003
1	FdUMP(10)IBA 08/2002
1	Thymidylate SynthaseIBA 08/2002
1	Messenger RNA (mRNA)IBA 03/2002
1	AntigensIBA 03/2002
1	Complementary DNA (cDNA)IBA 03/2002
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 03/2002
1	Tissue ExtractsIBA 03/2002

Therapy/Procedure

1	Length of Stay 03/2020
1	Therapeutics 03/2013
1	Immunotherapy 08/2005
1	Drug Therapy (Chemotherapy) 08/2002